Burns Wealth Management »

Revance Therapeutics shares owned by Burns Wealth Management

Quarter-by-quarter ownership of Revance Therapeutics (RVNC) shares owned by Burns Wealth Management from 13F filings

Historical chart of Burns Wealth Management investment in Revance Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Revance Therapeutics held by Burns Wealth Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Revance Therapeutics by Burns Wealth Management

Quarter filed Position value Share count Share price at filing
2023-03-31 $291k 9.0k 32.21
2022-09-30 $244k 9.0k 26.98
2021-09-30 $1.1M 41k 27.86
2021-06-30 $1.2M 41k 29.64
2021-03-31 $1.1M 41k 27.96
2020-12-31 $1.2M 42k 28.34
2020-09-30 $679k 27k 25.15
2020-06-30 $654k 27k 24.41
2020-03-31 $390k 26k 14.81
2019-12-31 $426k 26k 16.24
2019-09-30 $336k 26k 12.98
2019-06-30 $134k 10k 12.95
2019-03-31 $163k 10k 15.75
2018-12-31 $259k 13k 20.16
2018-09-30 $319k 13k 24.82
2018-06-30 $432k 16k 27.44
2018-03-31 $454k 15k 30.79
2017-12-31 $488k 14k 35.77